Table 4 —

Prevalence and RR of CHD*, MI, and stroke in relation to the presence of the metabolic syndrome

Metabolic syndrome
RRP
YesNo
NGT (n = 1,808)
 CHD9.24.11.73 (1.01–2.95)0.04
 Previous MI3.11.61.24 (0.52–2.97)0.62
 Previous stroke2.21.61.31 (0.48–3.62)0.59
IFG/IGT (n = 685)
 CHD11.05.31.82 (0.98–3.38)0.06
 Previous MI5.82.22.03 (0.81–5.08)0.13
 Previous stroke3.60.93.64 (1.01–13.13)0.05
Type 2 DM (n = 1,430)
 CHD27.113.52.23 (1.52–3.26)<0.001
 Previous MI11.24.72.26 (1.25–4.10)0.007
 Previous stroke5.72.91.79 (0.85–3.79)0.13
All subjects (n = 3,928)
 CHD21.45.52.96 (2.36–3.72)<0.001
 Previous MI9.02.12.63 (1.86–3.72)<0.001
 Previous stroke4.81.42.27 (1.47–3.50)<0.001
  • Data are % and RR (95% CI).

  • *

    * Defined as typical chestpain/use of nitroglycerine/previous MI;

  • definition of the syndrome was based on the recent WHO proposal (17);

  • adjusted for age and sex.